Actively Recruiting

Phase Not Applicable
Age: 4Weeks - 8Weeks
All Genders
NCT02812212

CTT on Renogram as an Early Marker of Significant Obstruction in Uretero-pelvic Junction Syndrome

Led by Centre Hospitalier Universitaire de la Réunion · Updated on 2022-09-29

75

Participants Needed

5

Research Sites

487 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Cortical transit time on diuretic renogram as an early marker of significant obstruction in antenatally detected uretero-pelvic junction syndrome

CONDITIONS

Official Title

CTT on Renogram as an Early Marker of Significant Obstruction in Uretero-pelvic Junction Syndrome

Who Can Participate

Age: 4Weeks - 8Weeks
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Infants aged 4 to 8 weeks
  • Diagnosed with ureteropelvic junction obstruction (UPJO) before birth by ultrasound
  • Antero-Posterior Renal Pelvic Diameter (APRPD) of 15 mm or greater confirmed by ultrasound between 1st and 15th day of life
  • Unilateral UPJO
  • Legal representatives have provided signed informed consent
  • At least one legal representative is affiliated with national social security
Not Eligible

You will not qualify if you...

  • Bilateral UPJO
  • Ureteral dilatation
  • Contralateral uropathy
  • Solitary kidney
  • Renal insufficiency
  • Severe associated disabilities (e.g., polymalformation syndromes)
  • Participation in another clinical trial
  • Contraindication to furosemide (acute renal insufficiency, hepatic encephalopathy, hypovolemia or dehydration, severe hypokalemia, severe hyponatremia)
  • Contraindication to radionuclide marker (allergy to active substance or excipients)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 5 locations

1

CHU de Bordeaux

Bordeaux, France, 33076

Actively Recruiting

2

CHU de Limoges

Limoges, France, 87000

Actively Recruiting

3

CHU de Nantes

Nantes, France, 44000

Not Yet Recruiting

4

CHU de Rennes

Rennes, France, 35023

Not Yet Recruiting

5

Centre Hospitalier Universitaire de La Réunion

Saint-Denis, France, 97400

Actively Recruiting

Loading map...

Research Team

L

Lucie Auzanneau

CONTACT

V

Valérie Fontaine

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here